Onyx Seeks Suitors After Rejecting Amgen’s Bid

July 1 (Bloomberg) -- Onyx Pharmaceuticals, the maker of the cancer drug Nexavar, said it is in contact with other possible acquirers after rejecting an unsolicited $120-a-share cash takeover bid from Amgen Onyx shares surged. Dominic Chu reports on Bloomberg Television's "Market Makers." (Source: Bloomberg)
Mr. Lee Is Singapore and Singapore Reflects Mr. Lee: Ong
37:40 - RSIS Executive Deputy Chairman Ong Keng Yong discusses the impact Lee Kuan Yew had on Singapore, its people and its neighbors with Bloomberg’s Haslinda Amin on “First Up.” (Source: Bloomberg)
  • Kleiner Perkins Attorney Speaks on Pao Suit Verdict
  • Kleiner's Not Guilty in Pao Case - Bloomerg West (03/27)
  • Sanford Says Pao Case Shows `Fundamental Problem'